STOCK TITAN

GOLD RIVER PRODS INC 10-Q Filings

GRPS OTC

Every 10-Q that GOLD RIVER PRODS INC (GRPS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow GRPS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GRPS filings page.

Rhea-AI Summary

Trans American Aquaculture, Inc. reported continued operating losses and no shrimp revenue in its quarter ended September 30, 2025. For the three months, revenue was $0 and the net loss was $171,642, improving from a loss of $575,325 a year earlier mainly due to lower cost of goods sold and reduced legal, professional, and payroll expenses. For the nine months, revenue was also $0 versus $315,145 in 2024, with the net loss narrowing to $489,387 from $1,143,656.

The balance sheet shows a strained financial position, with current liabilities of $4,719,609 and current assets of $340,123, creating a working capital deficit of $4,379,486 and a stockholders’ deficit of $3,758,603. Cash was just $509 at quarter-end, and shareholders have loaned about $1,646,636 at double‑digit interest rates. The company exited Chapter 11 bankruptcy in October 2025 but still faces going concern uncertainty and is relying on GHS Investments equity financing and preferred stock and warrant issuances to fund operations. Common shares outstanding were 1,805,926,955 as of January 14, 2026.

Rhea-AI Summary

Trans American Aquaculture, Inc. filed Amendment No. 1 to its Q2 2025 Form 10‑Q to revise the Balance Sheet and Statements of Stockholders’ Equity, reconciling the common stock issued value to the appropriate prior quarter and making a minor reclassification to a preferred stock to be issued line; it also furnishes XBRL Exhibit 101. No other changes to the original report.

Operations remain limited: Q2 2025 revenue was $0 (vs. $5,019 in Q2 2024) and net loss was $204,038. For the six months ended June 30, 2025, revenue was $0 (vs. $315,145 in 2024) and net loss was $317,745 (vs. $568,332). Cash was $198 at June 30, 2025, with current assets of $303,323 and current liabilities of $4,654,029, a working capital deficit of $4,350,706. Shares outstanding were 1,805,926,955 as of October 9, 2025.

The company discloses a going concern uncertainty and a voluntary Chapter 11 filing in December 2024, with a plan confirmation hearing scheduled for August 18, 2025. Management also reports a material weakness in internal control over financial reporting.

Rhea-AI Summary

Trans American Aquaculture (GRPS) filed its quarterly report, highlighting continued operating losses and liquidity stress. The company reported $0 revenue for both the three and six months ended June 30, 2025, with net losses of $204,038 and $317,745, respectively. Cash was $198 at quarter‑end, and current liabilities exceeded current assets by $4,350,706, indicating a significant working capital deficit.

The company remains under Chapter 11 protection following a December 2024 filing, with a plan confirmation hearing scheduled for August 18, 2025. Operations are paused; the company is maintaining broodstock only. Inventory totaled $302,409, primarily broodstock. Interest expense fell year over year, aiding a narrower loss.

To access funding, the company continued using preferred stock and warrant issuances with GHS, and it also disclosed an equity financing agreement that permits periodic common stock “puts.” Shares outstanding were 1,805,926,955 as of October 9, 2025. Management disclosed a going concern uncertainty and material weakness in internal control over financial reporting.